Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Chemotherapy with SPHM in the Treatment of Recurrent Adult and Childhood Malignant Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				BTRC-8525 NCI-T85-0236H, T85-0236


2.		Phase II Pilot Study of Chemotherapy with Spiromustine in Patients with Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				EST-PA-386 EST-P-A386


3.		Phase II Pilot Study of Chemotherapy with Spiromustine in Patients with Carcinomas Metastatic to the Brain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				EST-PA-387 EST-P-A387


4.		Phase I Evaluation of Spiromustine (NSC-172112)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				14 and over								NCI-W83-0250


5.		Phase I Evaluation of Spiromustine (NSC-172112)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								UMCC-8238 NCI-W82-1516, W82-1516


6.		Phase I Study of Spiromustine (NSC-172112) in Patients with Advanced Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				20 to 75				NCI				JHOC-8322 NCI-T83-0930W, T83-0930

Last Modified: 11/15/2007


7.		Phase I Study of Spirohydantoin Mustard (NSC-172112)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 13				NCI				WSU-A-49183 NCI-T83-0876W, T83-0876

Last Modified: 12/19/2007


8.		Phase I and Pharmacokinetic Study of Spirohydantoin Mustard in Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				NCI-83-C-198A NCI-T83-1289N, T83-1289


9.		Phase I Chemotherapy with Spirohydantoin Mustard for the Treatment of Pediatric Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				3 to 21				NCI				NCI-85-C-06A NCI-T84-0523N, T84-0523

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute